Latest Updates

News

Press Release

Diasome Pharmaceuticals announces the addition of globally recognized biopharma thought leader and CEO advisor Peter Tollman, PhD as a new Board Member

View Article
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press Release
View All

Diasome Pharmaceuticals Appoints Peter Tollman, Ph.D., as Chairman of the Board

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Launches Groundbreaking OPTI-2 Phase 2b Trial in Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Announces First Closing of Series C Financing Round

View article
Read more
Download article
Press Release
View All

Former Novo Nordisk Executive, Dr. Todd Hobbs, joins Diasome Pharmaceuticals as Chief Medical Officer

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Launches New Cancer Study

View article
Read more
Download article
Press Release
View All

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View article
Read more
Download article
Press Release
View All

Diasome to Present at the Solebury Trout Summer 2020 Private Company Showcase

View article
Read more
Download article
Press Release
View All

Diasome to Present at the LifeSci Partners Summer Symposium

View article
Read more
Download article
Press Release
View All

Diasome Announces Substantial Level 2 Hypoglycemia Event Reductions in its Phase 2b OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome to Present Data from Phase 2 OPTI-1 Clinical Trial at the 80th Annual American Diabetes Association Virtual Scientific Sessions

View article
Read more
Download article
Press Release
View All

Diasome Announces Positive Results from Phase 2 OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome to Present Additional Data on Hepatocyte Directed Vesicle Technology in Type 1 Diabetes at the Advanced Technologies & Treatment for Diabetes International Conference

View article
Read more
Download article
Press Release
View All

Diasome Appoints Dr. Jeremy Pettus as Chairman of Scientific Advisory Board

View article
Read more
Download article
Press Release
View All

Diasome Announces Publication of Phase 2b Results in Diabetes Care. First ever six-month study of a mealtime liver-targeted insulin.

View article
Read more
Download article
Press Release
View All

Diasome Announces Completion of Enrollment in Phase 2 OPTI-1 Study of Hepatocyte Directed Vesicle Technology in Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome’s Hepatocyte Directed Vesicle (HDV) Technology Met Primary Endpoint in Phase 2b Trial in Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome Announces Presentations at the American Diabetes Association’s 79th Scientific Sessions

View article
Read more
Download article
Press Release
View All

Diasome Announces First Patient Enrolled in Phase 2 Study of Hepatocyte Directed Vesicle Nanotechnology for People with Type 1 Diabetes

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. provides 16-month period company update

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. Receives Funding From JDRF T1D Fund

View article
Read more
Download article
Press Release
View All

Diasome Announces Dosing of First Type 1 Diabetes Patient in Randomized Phase 2b Clinical Trial of Injectable Hepatocyte Directed Vesicle (“HDV”) Technology With Insulin

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. and Lyfebulb, LLC Announce Partnership

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals Announces Clinical Trial Design Collaboration

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. Announces Issuance of Oral Insulin Patent by the US PTO

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. Announces Two New Members of Its Board of Directors Frank McCaney and Thomas McDonald Bring Added Industry Experience to Diasome’s Board

View article
Read more
Download article
Press Release
View All

Diasome Pharmaceuticals, Inc. Announces Notice of Allowance for Novel Nanotechnology Weight Loss Patent from the US PTO

View article
Read more
Download article